January:
iPLATO (myGP) joins the Huma family
In January we acquired iPLATO, expanding our reach to more than 26 million people in its network. Plus, with a proven ability to increase the use of healthcare services by up to 65%, iPLATO’s digital software, myGP, helps us to accelerate digital-first delivery of healthcare and research and bring ‘hospitals at home’ and decentralized clinical trials to even more customers.
February:
RPM study proves Huma saves 3.5 clinician hours per patient
In February we announced the exciting results of a study conducted alongside BMC (BioMed Central) Family Practice. With a 40% reduction in time spent reviewing patients, the study proved that app-based remote monitoring of patients could free up vital resources in terms of clinical team’s time, allowing a better reallocation of services.
Based on this finding, for every 100 patients, four fewer clinicians are required to monitor them remotely.
March:
Huma joins forces with AstraZeneca
In March, we announced our pioneering partnership with the world-leading pharmaceutical company, AstraZeneca, which is truly visionary in its embrace of digital technologies to improve medicines discovery and development. Rather than build these capabilities in-house, AZ has partnered with us to become their digital arm to deploy digital health tools to engage patients in care and treatment, and advance diversity through hybrid and decentralized clinical trials.
<div class="resources-cta">Read more</div>
April:
myGP reaches 2.5 million users
myGP (iPLATO) reached more than 2.5 million users in a single week in April 2022, a huge milestone for our new acquisition. Instrumental in increasing uptake of NHS services, including IAPT services, cancer screenings and health checks, myGP results in up to 65% higher uptake of services communicated through the app.
May:
Huma named 'best of the best’ at Prix Galien International
Considered the ‘Nobel-Prize of pharma’, this accolade, (awarded in May 2022 for ‘International Best Digital Health Solution’) marks our second Prix Galien Award win for our ‘hospital at home’ technology, which almost doubles clinical capacity and reduces readmissions by connecting patients to their care teams through a smartphone app.
June:
Huma partners with Xyla care to deliver virtual wards
In June, we partnered with Xyla Elective Care, a national provider of NHS England-funded elective services, to deliver tech-enabled virtual wards using Huma’s award-winning remote patient monitoring platform. Together, we’re supporting Xyla Elective Care’s network of more than 50 trusts and CCGs and 90,000+ patients.
July:
Huma named ‘Sifted tech partners to watch’
Sifted ranked the most promising startups across the UK in a weighted selection of new entries, older faces and fast-growing hits. Huma were proud to be earn the accolade ‘tech partner to watch’.
August:
Huma x NHS Wales cardiac study highlighted in The Times and BBC
In August we were thrilled to see The Times report on the impact of Huma, including how our medical device platform helped patients like David Watkins (69), by preventing hospital readmissions and getting people home sooner using data collected through our app.
September:
DeTap study results launched, in partnership with Stanford Medicine and Bayer
Huma’s technology was used in a fully virtual atrial fibrillation trial by Stanford Medicine and Bayer, in which 94% of patients were recruited in just 12 days. In September, we announced the results of the study, named DeTAP. The results included:
- 99% ECG and BP measurements completed
- 91% of televisits completed
- 86% of patients wanted to continue beyond the 6-month timeline
- 96% medication adherence
October:
Dan speaks at World Economic Forum’s Biotech Future Forum in Serbia
Our CEO, Dan Vahdat, joined leading experts at the World Economic Forum to discuss how start-ups are breaking new ground in biotech and changing the way we interact with the world, but also how the sector can earn trust, scale successfully and spot the brightest innovations.
November:
Huma team attends HLTH in Las Vegas
In November, we attended healthcare's #1 innovation event, HLTH in Las Vegas. We connected with healthcare leaders from across the globe, gained a wealth of insight and shared our visions for advancing predictive, proactive health for all.
December:
Huma hosts live expert webinars
In December we hosted two live webinars, with experts from the NHS, Stanford University Medical Center, University of Cambridge School of Clinical Medicine, Pfizer and AstraZeneca, sharing our knowledge on best practice for virtual wards and engagement in clinical trials.
